A clinical trial involving desmopressin, titled "DDAVP Effect by TEG6 in Cardiac Surgery," was listed as recruiting as of September 21, 2026. The trial is registered under identifier NCT07179991. No phase was specified in the available record. The study status is listed as recruiting, meaning the trial is currently enrolling participants. No outcome data, results, or efficacy information have been reported for this trial at this time. Desmopressin, also known as DDAVP, is an approved compound, and this trial update reflects only its current recruiting status within this specific study. No additional details about trial design, endpoints, or enrollment numbers were included in the event data. Readers interested in the broader context of desmopressin as a compound, including its approved uses and regulatory status, can refer to the compound overview for further background information.
Desmopressin Trial "DDAVP Effect by TEG6 in Cardiac Surgery" Now Recruiting
See the full desmopressin overview
Source: https://clinicaltrials.gov/study/NCT07179991